Co-Authors
This is a "connection" page, showing publications co-authored by Fernando Bozza and Marcelo Ferreira.
Connection Strength
0.118
-
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19. J Antimicrob Chemother. 2021 06 18; 76(7):1874-1885.
Score: 0.059
-
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil. Emerg Infect Dis. 2021 May; 27(5):1446-1453.
Score: 0.059